The Influence of Diffuse Left Anterior Descending Artery Lesions on Outcomes of Coronary Artery Bypass Grafting
Keywords:left anterior descending artery, diffuse coronary disease, coronary artery bypass surgery, coronary artery bypass grafting
Background: Diffuse coronary lesions adversely influence the outcomes of coronary artery bypass grafting (CABG). This study aimed to investigate the influence of diffuse left anterior descending artery (LAD) lesions on the outcomes
Methods: The data of 123 patients, who received elective isolated CABG with the left internal mammary artery bypassed to the LAD from January 2011 to June 2017, were collected. According to their lesions (≥50% diameter stenoses) ≤2cm or >2cm in the middle and distal segment of LAD, the patients were classified into a No Diffuse Lesion (NDL) group (69 patients) and a Diffuse Lesion (DL) group (54 patients). The rates of in-hospital mortality, 5-year all-cause mortality, and major cardiac events (MCEs) (i.e. myocardial infarction, angina, acute heart failure, and atrial fibrillation) were analyzed.
Results: According to the univariate analyses, the NDL group had fewer diffuse left circumflex artery (LCX) lesions (P = .001) and higher ventricular fibrillation (Vf) after aortic de-clamping (P = .03) than the DL group. According to the multivariate analyses, the in-hospital and 5-year all-cause mortality rates of the two groups did not significantly differ (P = .80 and P = .59). Otherwise, the DL group had a trend toward more MCEs (hazard ratio = 2.07, P = .061), but the difference clearly was insignificant after adjusting for diffuse LCX lesions and Vf after aortic
de-clamping (P = .104).
Conclusions: The results demonstrated that diffuse LAD lesions did not influence the risks of in-hospital mortality, 5-year all-cause mortality, or MCEs after CABG.
Alderman EL, Stadius M. 1992. The angiographie definitions of the Bypass Angioplasty Revascularization Investigation. Coronary Artery Disease. 3(12):1189-1208.
Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. 1985. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation. Dec;72(6 Pt 2):V71-78.
Byard RW, Keon WJ, Walley VM. 1988. Coronary endarterectomy: the long-term local effects. The American journal of cardiovascular pathology. 2(1):31-38.
Carey JS, Robertson JM, Misbach GA, Fisher AL. 2003. Relationship of hospital volume to outcome in cardiac surgery programs in California. The American surgeon. Jan;69(1):63-68.
Dourado LOC, Bittencourt MS, Pereira AC, et al. 2018. Coronary Artery Bypass Surgery in Diffuse Advanced Coronary Artery Disease: 1-Year Clinical and Angiographic Results. The Thoracic and cardiovascular surgeon. Sep;66(6):477-482.
Ferguson TB, Jr., Hammill BG, Peterson ED, DeLong ER, Grover FL. 2002. A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. The Annals of thoracic surgery. Feb;73(2):480-489; discussion 489-490.
Fukui T, Takanashi S, Hosoda Y. 2005. Coronary endarterectomy and stent removal in patients with in-stent restenosis. The Annals of thoracic surgery. Feb;79(2):558-563; discussion 563.
Goldman S, Zadina K, Moritz T, et al. 2004. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. Journal of the American College of Cardiology. Dec 7;44(11):2149-2156.
Gonzalez AA, Dimick JB, Birkmeyer JD, Ghaferi AA. 2014. Understanding the volume-outcome effect in cardiovascular surgery: the role of failure to rescue. JAMA surgery. Feb;149(2):119-123.
Graham MM, Chambers RJ, Davies RF. 1999. Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations. The Journal of thoracic and cardiovascular surgery. Oct;118(4):618-627.
Hahn JY, Song YB, Kim EK, et al. 2013. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation. Oct 22;128(17):1889-1896.
Hansen LS, Hjortdal VE, Andreasen JJ, Mortensen PE, Jakobsen CJ. 2015. 30-day mortality after coronary artery bypass grafting and valve surgery has greatly improved over the last decade, but the 1-year mortality remains constant. Annals of cardiac anaesthesia. Apr-Jun;18(2):138-142.
Harris PJ, Behar VS, Conley MJ, et al. 1980. The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease. Circulation. Aug;62(2):240-248.
Hermans WR, Foley DP, Rensing BJ, et al. 1993. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups. Am J Cardiol. Jul 1;72(1):14-20.
Hillis LD, Smith PK, Anderson JL, et al. 2011. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. Dec 6;124(23):2610-2642.
Jalal A. 2007. An objective method for grading of distal disease in the grafted coronary arteries. Interactive cardiovascular and thoracic surgery. Aug;6(4):451-455.
Jivraj N, Liew F, Marber M. 2015. Ischaemic postconditioning: cardiac protection after the event. Anaesthesia. May;70(5):598-612.
Karthik S, Srinivasan AK, Grayson AD, Jackson M, Mediratta NK. 2004. Left internal mammary artery to the left anterior descending artery: effect on morbidity and mortality and reasons for nonusage. The Annals of thoracic surgery. Jul;78(1):142-148.
Lamy A, Devereaux PJ, Prabhakaran D, et al. 2012. Off-pump or on-pump coronary-artery bypass grafting at 30 days. The New England journal of medicine. Apr 19;366(16):1489-1497.
Laskey WK, Schevchuck A. 2013. Postconditioning during percutaneous coronary intervention in acute myocardial infarction: continued difficulty in translation. Circulation. Oct 22;128(17):1858-1860.
Lawrie GM, Morris GC, Jr., Silvers A, et al. 1982. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation. Oct;66(4):717-723.
Leviner DB, Torregrossa G, Puskas JD. 2018. Incomplete revascularization: what the surgeon needs to know. Ann Cardiothorac Surg. Jul;7(4):463-469.
Lopes JA, Jorge S. 2013. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clinical kidney journal. Feb;6(1):8-14.
MacIntyre NR, Epstein SK, Carson S, Scheinhorn D, Christopher K, Muldoon S. 2005. Management of patients requiring prolonged mechanical ventilation: report of a NAMDRC consensus conference. Chest. Dec;128(6):3937-3954.
McLaran CJ, Gersh BJ, Sugrue DD, et al. 1987. Out-of-hospital cardiac arrest in patients without clinically significant coronary artery disease: comparison of clinical, electrophysiological, and survival characteristics with those in similar patients who have clinically significant coronary artery disease. British heart journal. Dec;58(6):583-591.
McNeil M, Buth K, Brydie A, MacLaren A, Baskett R. 2007. The impact of diffuseness of coronary artery disease on the outcomes of patients undergoing primary and reoperative coronary artery bypass grafting. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. May;31(5):827-833.
Morita Y, Mizuno J, Yoshimura T, Morita S. 2010. Efficacy of amiodarone on refractory ventricular fibrillation resistant to lidocaine and cardioversion during weaning from cardiopulmonary bypass in aortic valve replacement for severe aortic stenosis with left ventricular hypertrophy. Journal of anesthesia. Oct;24(5):761-764.
Myler RK, Shaw RE, Stertzer SH, et al. 1992. Lesion morphology and coronary angioplasty: current experience and analysis. Journal of the American College of Cardiology. Jun;19(7):1641-1652.
Neglia D, Rovai D, Caselli C, et al. 2015. Detection of significant coronary artery disease by noninvasive anatomical and functional imaging. Circulation. Cardiovascular imaging. Mar;8(3).
Nishi H, Miyamoto S, Takanashi S, et al. 2005. Optimal method of coronary endarterectomy for diffusely diseased coronary arteries. The Annals of thoracic surgery. Mar;79(3):846-852; discussion 852-843.
Otsuka F, Yahagi K, Sakakura K, Virmani R. 2013. Why is the mammary artery so special and what protects it from atherosclerosis? Ann Cardiothorac Surg. Jul;2(4):519-526.
Pereg D, Fefer P, Samuel M, et al. 2014. Native coronary artery patency after coronary artery bypass surgery. JACC. Cardiovascular interventions. Jul;7(7):761-767.
Ryan TJ, Faxon DP, Gunnar RM, et al. 1988. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. Aug;78(2):486-502.
Santini F, Casali G, Lusini M, et al. 2002. Mid-term results after extensive vein patch reconstruction and internal mammary grafting of the diffusely diseased left anterior descending coronary artery. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. Jun;21(6):1020-1025.
Seiler C. 2013. Assessment and impact of the human coronary collateral circulation on myocardial ischemia and outcome. Circulation. Cardiovascular interventions. Dec;6(6):719-728.
Shroyer AL, Grover FL, Hattler B, et al. 2009. On-pump versus off-pump coronary-artery bypass surgery. The New England journal of medicine. Nov 5;361(19):1827-1837.
Tanaka A, Ishii H, Oshima H, et al. 2016. Progression from stenosis to occlusion in the proximal native coronary artery after coronary artery bypass grafting. Heart and vessels. Jul;31(7):1056-1060.
Tasdemir O, Kiziltepe U, Karagoz HY, Yamak B, Korkmaz S, Bayazit K. 1996. Long-term results of reconstructions of the left anterior descending coronary artery in diffuse atherosclerotic lesions. The Journal of thoracic and cardiovascular surgery. Sep;112(3):745-754.
Tsagalou E, Chieffo A, Iakovou I, et al. 2005. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. Journal of the American College of Cardiology. May 17;45(10):1570-1573.
Walley VM, Byard RW, Keon WJ. 1991. A study of the sequential morphologic changes after manual coronary endarterectomy. The Journal of thoracic and cardiovascular surgery. Dec;102(6):890-894.
Watanabe G, Yashiki N, Tomita S, Yamaguchi S. 2011. Potassium-induced cardiac resetting technique for persistent ventricular tachycardia and fibrillation after aortic declamping. The Annals of thoracic surgery. Feb;91(2):619-620.
Zattera GF, D'Armini AM, Vigano M. 2011. Late angiographic changes of the left anterior descending coronary artery following removal of multiple occluded stents and on-lay patching with the left internal mammary artery. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. Dec;40(6):1529-1530.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).